-
Bristol Myers to build first cell therapy factory in Europe — Teva CEO Schultz sees a 35% raise despite company's legal woes — Why Biogen Q1 earnings weren't good enoughSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
PW 3 year MDX report card
Discussion in 'GE Healthcare' started by Anonymous, Jan 3, 2012 at 7:33 PM.